CORDIS
EU research results

CORDIS

English EN
Implementation of cost-optimized childhood vision and hearing screening programmes in middle-income countries in Europe

Implementation of cost-optimized childhood vision and hearing screening programmes in middle-income countries in Europe

Objective

Screening for vision and hearing disorders in children has shown to be highly effective. EU-directive 16620/11 invites EU-member states to give priority to such screening programmes. Early detection and treatment of a lazy eye (prevalence 3%) prevents lifelong visual impairment. Early detection and treatment of hearing impairment (prevalence 0.15%) prevents delayed speech and language development.
Across Europe inequity exists in the provision of childhood vision and hearing screening programmes (VAHSPs). High-Income Countries (HICs) have VAHSPs, but they vary with regard to age and frequency of testing, tests used, uptake, screening professionals, referral pathway and funding. This makes it difficult for healthcare providers and policy makers to decide what VAHSP to implement in Low- to Middle-Income Countries (LMICs) and how.
In this study, cost-optimised, evidence-based VAHSPs will be implemented in two LMICs, based on collated evidence from existing VAHSPs in Europe. Data on VAHSPs, demography, administration, general screening, screening professions, uptake and treatment availability will be gathered in an established network of professionals in 41 European countries and used in a disease/health system modelling framework to predict benefits and cost in the most optimal health system, taking regional diversity and organisational and resource requirements into account.
Model-developed VAHSPs will be tested in the county of Cluj in Romania for vision, and in three counties in Albania for hearing screening. A generic strategy for implementation will be developed by detailed tracking, and from identified requirements, facilitators and barriers. The decision-analytic modelling framework and the strategy for implementation will be packed into a transferable TOOLKIT that will assist healthcare providers and policy makers worldwide in their decisions to introduce or modify VAHSPs, and increase effectiveness, efficiency and equity of child healthcare.

Coordinator

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

Address

Dr Molewaterplein 40
3015 Gd Rotterdam

Netherlands

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 1 489 960

Participants (8)

Sort alphabetically

Sort by EU Contribution

Expand all

THE UNIVERSITY OF SHEFFIELD

United Kingdom

EU Contribution

€ 501 315

THE UNIVERSITY OF READING

United Kingdom

EU Contribution

€ 103 640

KAROLINSKA INSTITUTET

Sweden

EU Contribution

€ 400 098

JOHANN WOLFGANG GOETHE-UNIVERSITATFRANKFURT AM MAIN

Germany

EU Contribution

€ 75 500

UNIVERSITATEA DE MEDICINA SI FARMACIE IULIU HATIEGANU CLUJ-NAPOCA

Romania

EU Contribution

€ 424 931,25

UNIVERSITETI I MJEKESISE TIRANE

Albania

EU Contribution

€ 817 050

DIRECTIA DE ASISTENTA SOCIALA SI MEDICALA

Romania

EU Contribution

€ 125 068,75

STICHTING COUNTRY-COMMITTEES JOINT-PARTNERSHIP OF EUSCREEN STUDY CONSORTIUM

Netherlands

EU Contribution

€ 246 000

Project information

Grant agreement ID: 733352

Status

Ongoing project

  • Start date

    1 January 2017

  • End date

    31 December 2020

Funded under:

H2020-EU.3.1.6.

  • Overall budget:

    € 4 255 671,25

  • EU contribution

    € 4 183 563

Coordinated by:

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

Netherlands